Giuseppe Curigliano, President Elect of ESMO and Member of the Editorial Board at OncoDaily, shared a post on LinkedIn, adding:
“Excited to welcome Prof. Dr. Christian Blank to IEO!
A great opportunity to strengthen and grow our melanoma program with world-class expertise.”
Quoting The European Institute of Oncology post LinkedIn:
“From October 1st, Professor Christian Blank, an internationally renowned expert who has changed the scenario of treatment for melanomas thanks to neoadjuvant immunotherapy, will be the new Director of the IEO multidisciplinary program dedicated to Melanoma and Sarcomas.
‘This choice will guarantee the Institute a further step forward in the treatment of this tumor – declares our Scientific Director Roberto Orecchia – and at the same time to acquire a leading role in the field of immunotherapy, with a great boost to research’, also useful for other oncological diseases.
Best wishes for good work to Prof. Blank and his entire team!.”
Read more posts about Neoadjuvant Immunotherapy on OncoDaily.